275 related articles for article (PubMed ID: 25510391)
1. Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation.
Shinjoh M; Hoshino K; Takahashi T; Nakayama T
Vaccine; 2015 Jan; 33(5):701-7. PubMed ID: 25510391
[TBL] [Abstract][Full Text] [Related]
2. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation.
Shinjoh M; Miyairi I; Hoshino K; Takahashi T; Nakayama T
Vaccine; 2008 Dec; 26(52):6859-63. PubMed ID: 18930096
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
[TBL] [Abstract][Full Text] [Related]
7. Live virus immunization after orthotopic liver transplantation.
Khan S; Erlichman J; Rand EB
Pediatr Transplant; 2006 Feb; 10(1):78-82. PubMed ID: 16499592
[TBL] [Abstract][Full Text] [Related]
8. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.
Rowhani-Rahbar A; Fireman B; Lewis E; Nordin J; Naleway A; Jacobsen SJ; Jackson LA; Tse A; Belongia EA; Hambidge SJ; Weintraub E; Baxter R; Klein NP
JAMA Pediatr; 2013 Dec; 167(12):1111-7. PubMed ID: 24126936
[TBL] [Abstract][Full Text] [Related]
9. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
[TBL] [Abstract][Full Text] [Related]
10. Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation.
Aoki T; Kamimura T; Yoshida S; Mori Y; Kadowaki M; Kohno K; Ishihara D; Urata S; Sugio T; Kamezaki K; Kato K; Ito Y; Eto T; Akashi K; Miyamoto T
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1576-1585. PubMed ID: 30959161
[TBL] [Abstract][Full Text] [Related]
11. Combination measles, mumps, rubella and varicella vaccine.
Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of immunization for pre- and post- liver transplant children.
Kano H; Mizuta K; Sakakihara Y; Kato H; Miki Y; Shibuya N; Saito M; Narita M; Kawarasaki H; Igarashi T; Hashizume K; Iwata T
Transplantation; 2002 Aug; 74(4):543-50. PubMed ID: 12352917
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.
Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Arai K; Ito R; Kawai T; Ito S
PLoS One; 2020; 15(10):e0240217. PubMed ID: 33002085
[TBL] [Abstract][Full Text] [Related]
14. The combination measles, mumps, rubella and varicella vaccine in healthy children.
Arbeter AM; Baker L; Starr SE; Plotkin SA
Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
[TBL] [Abstract][Full Text] [Related]
15. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center.
Diana A; Posfay-Barbe KM; Belli DC; Siegrist CA
Pediatr Transplant; 2007 Feb; 11(1):31-7. PubMed ID: 17239121
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
[TBL] [Abstract][Full Text] [Related]
20. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
